Stay updated on Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.

Latest updates to the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page
- Check7 days agoChange DetectedAdded Melanoma to the related topics section and linked MedlinePlus Genetics as a related topics reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check14 days agoChange DetectedAdded Revision: v3.4.2 to the page. Removed the funding-notice, Melanoma-related topics, and the previous Revision: v3.4.1 reference.SummaryDifference0.8%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding with guidance to check opm.gov for status updates, and updated the revision to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedShow glossary option is now visible, and boilerplate labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; the revision tag was updated from v3.3.4 to v3.4.0.SummaryDifference0.3%

- Check42 days agoChange DetectedMelanoma is added as a related topic and MedlinePlus Genetics is linked. The page revision is updated from v3.3.3 to v3.3.4.SummaryDifference0.3%

- Check64 days agoChange DetectedAdded a footer line: Revision: v3.3.3; several footer links were removed, including HHS Vulnerability Disclosure, Melanoma, related topics, MedlinePlus Genetics, and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.